Show simple item record

dc.contributor.authorCreese, B
dc.contributor.authorArathimos, R
dc.contributor.authorAarsland, D
dc.contributor.authorBallard, C
dc.contributor.authorBrooker, H
dc.contributor.authorHampshire, A
dc.contributor.authorCorbett, A
dc.contributor.authorIsmail, Z
dc.date.accessioned2023-04-14T15:37:55Z
dc.date.issued2023-04-30
dc.date.updated2023-04-14T15:16:58Z
dc.description.abstractINTRODUCTION: Late-life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship to cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2,750 people over 50 without dementia were analyzed. Incident cognitive impairment was operationalized using the IQCODE and psychosis was rated using the Mild Behavioral Impairment Checklist (henceforth MBI-psychosis). The whole sample was analyzed before stratification on APOE-ε4 status. RESULTS: In Cox proportional hazards models, MBI-psychosis had a higher hazard for cognitive impairment relative to the No Psychosis group (hazard ratio (HR):3.6, 95% CI:2.2-11 6, p<0.0001). The hazard for MBI-psychosis was higher in APOE-ε4 carriers and there was an interaction between the two (HR for interaction: 3.4, 95% CI:1.2-9.8, p=0.02). DISCUSSION: Psychosis assessment in the MBI framework is associated with incident cognitive impairment in advance of dementia, these symptoms may be particularly important in the context of APOE genotype.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipNational Institute for Health and Care Research (NIHR)en_GB
dc.description.sponsorshipCanadian Institutes of Health Researchen_GB
dc.identifier.citationVol. 9 (2), article e12386en_GB
dc.identifier.doi10.1002/trc2.12386
dc.identifier.grantnumberMC_PC_17189en_GB
dc.identifier.grantnumberBCA 2633en_GB
dc.identifier.urihttp://hdl.handle.net/10871/132910
dc.identifierORCID: 0000-0001-6490-6037 (Creese, Byron)
dc.language.isoenen_GB
dc.publisherWiley / Alzheimer’s Associationen_GB
dc.rights© 2023 The Authors. Alzheimer’s & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectmild behavioral impairmenten_GB
dc.subjectAPOEen_GB
dc.subjectneuropsychiatric symptomsen_GB
dc.subjectpsychosisen_GB
dc.subjectcognitionen_GB
dc.titleLate-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s diseaseen_GB
dc.typeArticleen_GB
dc.date.available2023-04-14T15:37:55Z
dc.identifier.issn2352-8737
dc.descriptionThis is the final version. Available on open access from Wiley via the DOI in this recorden_GB
dc.identifier.journalAlzheimer's and Dementia: Translational Research and Clinical Interventionsen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-04-01
dcterms.dateSubmitted2022-10-18
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-04-01
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-04-14T15:17:00Z
refterms.versionFCDAM
refterms.dateFOA2023-05-09T14:55:01Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. Alzheimer’s & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Alzheimer’s & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.